{"lang": "en", "created_at": "2020-06-28T17:35:56.000Z", "source": "Twitter Web App", "entities": {"urls": [{"start": 199, "end": 222, "url": "https://t.co/SNhKLTFFQ5", "expanded_url": "https://finance.yahoo.com/news/83-survival-covid-19-patients-100010532.html", "display_url": "finance.yahoo.com/news/83-surviv\u2026", "status": 200, "unwound_url": "https://finance.yahoo.com/news/83-survival-covid-19-patients-100010532.html"}], "mentions": [{"start": 0, "end": 11, "username": "dallasnews", "id": "15679641"}, {"start": 12, "end": 19, "username": "msumak", "id": "33268930"}]}, "reply_settings": "everyone", "text": "@dallasnews @msumak Mesoblast remestemcel-l for toughest Covid19 ADRS. flips 88% ventilator death rate into 83% survival rate. \nInterim results of 300 person trial very soon. \nWill help many people.\nhttps://t.co/SNhKLTFFQ5", "public_metrics": {"retweet_count": 2, "reply_count": 0, "like_count": 1, "quote_count": 0}, "referenced_tweets": [{"type": "replied_to", "id": "1277227640873779201"}], "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "29", "name": "Events [Entity Service]", "description": "Entity Service related Events domain"}, "entity": {"id": "1219057585707315201", "name": "COVID-19: Latest news updates from around the world", "description": "This page is a timeline of Tweets with the latest information and updates on COVID-19 from experts, journalists, health authorities and other trusted sources from around the world. For more on COVID-19, visit: twitter.com/explore/tabs/covid-19"}}], "conversation_id": "1277227640873779201", "author_id": "788899165220671488", "possibly_sensitive": false, "id": "1277294674672263168", "in_reply_to_user_id": "15679641"}